Recombinant multi-species Cryptochrome 2/CRY2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cryptochrome 2/CRY2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a flavin adenine dinucleotide-binding protein that is a key component of the circadian core oscillator complex, which regulates the circadian clock. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene have been associated with altered sleep patterns. The encoded protein is widely conserved across plants and animals. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2014]
The Alternative Names of target: CRY2,Cry2,Cryptochrome 2,Cryptochrome-2,D130054K12Rik,HCRY2,PHLL2

Target products collectionGo to Cryptochrome 2/CRY2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T51908-Ag-1/ GM-Tg-hg-T51908-Ag-2 Human Cryptochrome 2/CRY2 protein Human
GM-Tg-rg-T51908-Ag-1/ GM-Tg-rg-T51908-Ag-2 Rat Cryptochrome 2/CRY2 protein Rat
GM-Tg-mg-T51908-Ag-1/ GM-Tg-mg-T51908-Ag-2 Mouse Cryptochrome 2/CRY2 protein Mouse
GM-Tg-cynog-T51908-Ag-1/ GM-Tg-cynog-T51908-Ag-2 Cynomolgus/Rhesus macaque Cryptochrome 2/CRY2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T51908-Ag-1/ GM-Tg-felg-T51908-Ag-2 Feline Cryptochrome 2/CRY2 protein Feline
GM-Tg-cang-T51908-Ag-1/ GM-Tg-cang-T51908-Ag-2 Canine Cryptochrome 2/CRY2 protein Canine
GM-Tg-bovg-T51908-Ag-1/ GM-Tg-bovg-T51908-Ag-2 Bovine Cryptochrome 2/CRY2 protein Bovine
GM-Tg-equg-T51908-Ag-1/ GM-Tg-equg-T51908-Ag-2 Equine Cryptochrome 2/CRY2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T51908-Ag-1/ GM-Tg-hg-T51908-Ag-2; GM-Tg-rg-T51908-Ag-1/ GM-Tg-rg-T51908-Ag-2;
GM-Tg-mg-T51908-Ag-1/ GM-Tg-mg-T51908-Ag-2; GM-Tg-cynog-T51908-Ag-1/ GM-Tg-cynog-T51908-Ag-2;
GM-Tg-felg-T51908-Ag-1/ GM-Tg-felg-T51908-Ag-2; GM-Tg-cang-T51908-Ag-1/ GM-Tg-cang-T51908-Ag-2;
GM-Tg-bovg-T51908-Ag-1/ GM-Tg-bovg-T51908-Ag-2; GM-Tg-equg-T51908-Ag-1/ GM-Tg-equg-T51908-Ag-2
Products Name Cryptochrome 2/CRY2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Cryptochrome 2/CRY2
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cryptochrome 2/CRY2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.